Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The role of interleukin-1β in the immune response to contact allergens

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. A comparison between self-reported hand eczema and self-reported signs and symptoms of skin lesions indicating hand eczema

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Assessment of hand eczema severity: What's new?

    Research output: Contribution to journalLetterResearchpeer-review

  1. Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Can patient-reported outcome measures be used to predict consultation needs in patients with psoriasis? A survey study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Biomarkers of disease progression in people with psoriasis: a scoping review*

    Research output: Contribution to journalReviewResearchpeer-review

  5. Biomarkers of systemic treatment response in people with psoriasis: a scoping review

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Interleukin-1β (IL-1β) is an important pro-inflammatory cytokine that has an effect on almost every cell lineage in the body. By blocking IL-1β and investigating the IL-1β signaling pathway, several studies have demonstrated a central role of IL-1β in the response to contact allergens. This review summarizes the current literature regarding the basic immunological mechanisms mediated by IL-1β in the different phases of allergic contact dermatitis (ACD) and highlights potential IL-1β-targeted treatment options, which in the future may be relevant in the treatment of patients with ACD. This review is based primarily on studies using various mouse models and human in vitro studies, since clinical studies on the effect of IL-1β in ACD are lacking.

Original languageEnglish
JournalContact Dermatitis
Volume85
Issue number4
Pages (from-to)387-397
Number of pages11
ISSN0105-1873
DOIs
Publication statusPublished - Oct 2021

Bibliographical note

Publisher Copyright:
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

    Research areas

  • allergic contact dermatitis, immunology, interleukin-1β, T cells

ID: 69204235